Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.
Hope TA, Allen-Auerbach M, Bodei L, Calais J, Dahlbom M, Dunnwald LK, Graham MM, Jacene HA, Heath CL, Mittra ES, Wright CL, Fendler WP, Herrmann K, Taïeb D, Kjaer A. Hope TA, et al. Among authors: fendler wp. J Nucl Med. 2023 Feb;64(2):204-210. doi: 10.2967/jnumed.122.264860. J Nucl Med. 2023. PMID: 36725249 Free article. No abstract available.
[Procedure Guideline for Prostate Cancer Imaging with PSMA-ligand PET/CT].
Afshar-Oromieh A, Eiber M, Fendler W, Schmidt M, Rahbar K, Ahmadzadehfar H, Umutlu L, Hadaschik B, Hakenberg OW, Fornara P, Kurth J, Neels O, Wester HJ, Schwaiger M, Kopka K, Haberkorn U, Herrmann K, Krause BJ; Deutsche Gesellschaft für Urologie e. V. (DGU); Deutsche Röntgengesellschaft e. V. (DRG). Afshar-Oromieh A, et al. Nuklearmedizin. 2023 Feb;62(1):5-19. doi: 10.1055/a-1984-8167. Epub 2023 Feb 6. Nuklearmedizin. 2023. PMID: 36746147 German.
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma.
Hamacher R, Lanzafame H, Mavroeidi IA, Pabst KM, Kessler L, Cheung PF, Bauer S, Herrmann K, Schildhaus HU, Siveke JT, Fendler WP. Hamacher R, et al. Among authors: fendler wp. PET Clin. 2023 Jul;18(3):361-367. doi: 10.1016/j.cpet.2023.02.008. Epub 2023 Mar 28. PET Clin. 2023. PMID: 36997366 Review.
A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy.
Kuo PH, Yoo DC, Avery R, Seltzer M, Calais J, Nagarajah J, Weber WA, Fendler WP, Hofman MS, Krause BJ, Brackman M, Kpamegan E, Ghebremariam S, Benson T, Catafau AM, Kendi AT. Kuo PH, et al. Among authors: fendler wp. J Nucl Med. 2023 Aug;64(8):1259-1265. doi: 10.2967/jnumed.122.265077. Epub 2023 May 25. J Nucl Med. 2023. PMID: 37230533 Free PMC article.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen WJG, Rahbar K, Schoder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Kratochwil C, et al. Among authors: fendler wp. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2830-2845. doi: 10.1007/s00259-023-06255-8. Epub 2023 May 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37246997 Free PMC article.
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers.
Sollini M, Calais J, Chiti A, Emmett L, Fanti S, Fendler W, Herrmann K, Hope TA, Sartor O, Shuch B, Tagawa S, Hofman MS. Sollini M, et al. Eur Urol. 2024 Oct 19:S0302-2838(24)02641-1. doi: 10.1016/j.eururo.2024.09.036. Online ahead of print. Eur Urol. 2024. PMID: 39428326 Review.
265 results